We are live on
!
Find out more
TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
1-Year Est. Return
15.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$726M
AUM Growth
+$18.2M
(+2.6%)
Cap. Flow
+$4.73M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
81
New
7
Increased
30
Reduced
28
Closed
3
Top Buys
| 1 |
United Parcel Service
UPS
|
+$1.89M |
| 2 |
Starbucks
SBUX
|
+$919K |
| 3 |
Mettler-Toledo International
MTD
|
+$833K |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
+$748K |
| 5 |
State Street
STT
|
+$654K |
Top Sells
| 1 |
Brown-Forman Class B
BF.B
|
+$5.69M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$1.87M |
| 3 |
SLB Ltd
SLB
|
+$1.62M |
| 4 |
Kimberly-Clark
KMB
|
+$916K |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$803K |
Sector Composition
| 1 | Healthcare | 44.52% |
| 2 | Technology | 11.82% |
| 3 | Industrials | 10.11% |
| 4 | Consumer Discretionary | 6.69% |
| 5 | Financials | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cognex
CGNX
$10.6B
| $38.4M | 5.29% |
739,400
+6,915
| +0.9% | +$409K |
|
|
TIF
2
DELISTED
Tiffany & Co.
TIF
| $33.4M | 4.6% |
342,336
-7,784
| -2% | -$803K |
|
3
Neogen
NEOG
$2.25B
| $30.7M | 4.23% |
917,692
+15,975
| +2% | +$481K |
|
4
Analog Devices
ADI
$185B
| $30.2M | 4.16% |
331,695
+3,424
| +1% | +$312K |
|
5
Idexx Laboratories
IDXX
$45.4B
| $29.3M | 4.04% |
153,230
-1,090
| -0.7% | -$201K |
|
|
RTN
6
DELISTED
Raytheon Company
RTN
| $28.8M | 3.96% |
133,322
+475
| +0.4% | +$98.3K |
|
7
Mastercard
MA
$487B
| $27.3M | 3.75% |
155,615
-335
| -0.2% | -$57.3K |
|
8
Insulet
PODD
$11.4B
| $26.3M | 3.62% |
303,040
+755
| +0.2% | +$58.6K |
|
|
9
Brown-Forman Class B
BF.B
$11.9B
| $26.1M | 3.59% |
479,536
-120,028
| -20% | -$5.69M |
|
10
Johnson & Johnson
JNJ
$602B
| $25.2M | 3.46% |
196,291
-1,048
| -0.5% | -$142K |
|
11
Danaher
DHR
$145B
| $24.2M | 3.33% |
278,317
+4,924
| +2% | +$431K |
|
|
ABMD
12
DELISTED
Abiomed Inc
ABMD
| $23.3M | 3.21% |
80,180
-455
| -0.6% | -$115K |
|
13
Honeywell
HON
$71.7B
| $22.9M | 3.16% |
175,644
+2,762
| +2% | +$382K |
|
14
DexCom
DXCM
$30.1B
| $21.5M | 2.96% |
1,159,316
+37,136
| +3% | +$549K |
|
15
Inogen
INGN
$180M
| $20.6M | 2.84% |
167,915
+3,860
| +2% | +$471K |
|
|
NVO
16
Novo Nordisk
NVO
$228B
| $20M | 2.75% |
811,990
-970
| -0.1% | -$25.5K |
|
17
Biogen
BIIB
$30.8B
| $19.8M | 2.72% |
72,227
-1,390
| -2% | -$431K |
|
|
18
Starbucks
SBUX
$124B
| $19.2M | 2.64% |
331,373
+15,903
| +5% | +$919K |
|
19
Ross Stores
ROST
$74.7B
| $17.2M | 2.37% |
220,983
+7,503
| +4% | +$595K |
|
|
NVRO
20
DELISTED
NEVRO CORP.
NVRO
| $14.6M | 2.01% |
168,805
+9,260
| +6% | +$748K |
|
21
Henry Schein
HSIC
$10.1B
| $13.2M | 1.82% |
251,255
-1,773
| -0.7% | -$98.2K |
|
22
Amgen
AMGN
$201B
| $13.1M | 1.81% |
77,024
-750
| -1% | -$138K |
|
|
23
Mettler-Toledo International
MTD
$27B
| $12.7M | 1.75% |
22,110
+1,325
| +6% | +$833K |
|
24
Dentsply Sirona
XRAY
$2.77B
| $12.6M | 1.74% |
250,918
+5,036
| +2% | +$297K |
|
25
AbbVie
ABBV
$449B
| $11.8M | 1.62% |
124,550
-1,300
| -1% | -$143K |
|
Similar funds
IAS
ACM
MFBTD
SGAM
AB
NTC
DCM
DSI